GA overall presentation - EAHP

Document Sample
GA overall presentation - EAHP Powered By Docstoc
					 Welcome to the
EAHP 41st General

  3-5 June 2011
Welcome - Programme of the Day
•   09.00 – 10.45: points 1 to 5 of the agenda
•   10.45 – 11.15: coffee break
•   11.15 – 12.30: point 6
•   12.30 – 14.00: lunch break
•   14.00 – 15.30: points 7 & 8
•   15.30 – 16.00: coffee break
•   16.00 – 17.00: point 9
•   GA adjourns for the day.
•   18.30: meet in the hotel lobby and visit of the Trinity
    College with dinner in one of the historic dining

                                                  Point 1 - Programme

Welcome – Delegates from 24 countries

  Austria          Germany    Slovakia
  Belgium          Greece     Slovenia
  Bulgaria         Hungary    Spain
  Croatia          Ireland    Sweden
  Czech Republic   Italy      Switzerland
  Denmark          Norway     The Netherlands
  Estonia          Poland
  Finland          Portugal
  FYROM            Serbia

                                            Point 1 -Delegates

Welcome – new delegates
•   Austria: Silvia Hetz
•   Belgium: Claudine Legneel
•   Belgium: Sophie Lorent
•   Bulgaria: Svetla Georgieva
•   Bulgaria: Sava Ognyanov
•   Croatia: Miroslav Kota
•   FYROM: Biljana Lazarova
•   Greece: Despina Makridaki
•   Greece: Irini Tsikalaki
•   Norway: Richard Fjellaksel
•   Portugal: Claudia Neto
•   Serbia: Dragana Rajinac
•   Serbia:
                                 Point 1- Delegates

Apologies received from:
  • Turkey
  • Latvia
  • Luxembourg
  • Bosnia & Herzegovina
  • France

  • Lithuania
  • UK

                           Point 1- delegates

    Order of items on the agenda
and notification of any other business

                                   Point 2 - Agenda

  Adoption of the 2010
general assembly minutes
         - Vote -

                         Point 3 – Minutes GA 2010

Report by the president
Los Angeles   200 flights
Dallas        343 hours
              162.534 km

                      Private flight

• Goal 1: Integrity of EAHP

• Create a code of conduct

• The code was well accepted and had no
  negative effect on support by industry

                                           Code of conducts

• Goal 2: Make authorities and patients aware of
  Hospital Pharmacy
• Approach actively national and European authorities
• Advocacy
   – Attend European Commission events related to
     pharmacy and health in general
   – meet with representatives of the European
     Commission to discuss education in pharmacy and
     freedom of movement for the recognition of the
     specialization in HP

   – S. point 6 of the GA agenda

                                   Visibility of Hospital Pharmacy and advocacy

The key actions

1)   Update and standardize promotion material

     a)   Working group

     b)   Literature giving evidence of HP impact on patient safety

     c)   Motto : “Hospital Pharmacists making the difference in medication use”

                                                   Visibility of Hospital Pharmacy and advocacy

Literature giving evidence of HP impact on patient safety

                                      Visibility of Hospital Pharmacy and advocacy

The key actions

2)   Visit national authorities by request of members

5)   Continue promotion of Hospital Pharmacy specialisation

I lobbied for the specialisation on hospital Pharmacy in
meetings with

•German Ministry of Health
•Hungarian Ministry of Health

•Italian EU-lobbyists
•DG Market (Mr. Tiedje, 1 meeting)

                                     Visibility of Hospital Pharmacy and advocacy

The key actions

3)   Collaboration with FIP, EMA and PHIS-Project

     s. also point 6 of the GA agenda

4)   Create awareness in and get support by other health
     professionals (physicians, nurses, technicians) and

                                        Visibility of Hospital Pharmacy and advocacy

•ESOP   (European Society of Oncology Pharmacy)
•ESCP   (European Society of Clinical Pharmacy)

•PGEU (Pharmacists Group of the European Union),
        I attended the GA in Brügge

•HOPE (European Hospital and Health Care Federation)
•FIP    (Fédération Internationale Pharmaceutique)
        Jacqueline Surugue new president of the section HP
        Robert Moss new Vice-President for Europe of the section HP

•ASHP   (American Society of Health-Systems Pharmacists),
        I attended as observer the strategy meeting in Dallas

•EIPG   (European Industry Pharmacists Group),
        I attended the GA in Madrid

•EAFP   (European Association of the Faculties of Pharmacy)

                                           Visibility of Hospital Pharmacy and advocacy

•EPSA   (European Pharmacy Students Association),
        I attended their international reception in Brussels

        2 meetings

•AEMH (European Association of Senior Hospital Physicians)
•FEMS (Federation of European salaried physicians)
•EISCM (European Society of Intensive Care Medicine)
•ENF (European Nurses Federation)
•EPF (European Patients Forum)

•EAPT (European Association of Pharmaceutical Technicians)
        1 meeting in Brussels

                                            Visibility of Hospital Pharmacy and advocacy

   Congresses and presentations (1)

•EAFP Catania
        presentation on Hospital Pharmacy and trials

•FIP Lisbon
        presentation on EAHP strategy 2012

•TAHP Ankara (Turkish Association of Hospital Pharmacists)
        presentation on Hospital Pharmacy in Europe

•SIFO Cagliari
        Presentation on Hospital Pharmacy specialisation

•ADKA Freiburg + Berlin (German Association of Hospital Pharmacists)
        speech on the centenary congress in Berlin

                                           Visibility of Hospital Pharmacy and advocacy

  Congresses and presentations (2)

•EPSA Lisbon
      Presentation on pharmacovigilance

•ESCP Lyon

•ASHP Anaheim

•EAHP Vienna
      I was only active as musicians

•AEMH Montreux
      presentation on collaborative care

                                           Visibility of Hospital Pharmacy and advocacy

• Goal 3: Development of Hospital Pharmacy in
  Europe and education of hospital pharmacists

• Define the levels of education and development of
  Hospital Pharmacy in Europe

                                   Education and Professional Development

• The key actions

1)   The survey 2010

     s. Point 5 of the GA agenda

2)   Translate the Basel statements in level of Hospital
     Pharmacy development in Europe

     The working group is integrated as follow up of the

     s. Point 6.5 of the GA agenda

                                          Education and Professional Development

• The key actions


     a)   Define the competencies for foundation level (Bologna process
     b)   Define the competencies for Hospital Pharmacy Specialisation
     c)   Working group (JSy,RF) until end of 2010
     d)   Collaboration with faculties of pharmacy (EAFP), students (EPSA)

s. Point 6.5 of the GA agenda

                                                Education and Professional Development

• Goal 4: Efficiency of the association

1) Standardize operations in the office

2) Support in addition to the president other board members
   by contracts with their hospitals

3) Hire a Pharmacists?

s. Point 10 of the GA agenda

                                                     Internal matters

Highlights of Board’s activities (1)
 2010 Survey:
                                                   See point 5 of the GA
 Finalised negotiations, liaised with country      agenda
 coordinators and completion of survey

 Future publisher of EJHP: finalise negotiations
 and resulting financial implications for EAHP
 Begin transition with editorial board meetings
 being arranged by EAHP and BMJ                    See point 8 of the GA
 Begin contract negotiations with EiC and other
 Continue discussions with PPME regarding
 Review question of copyrights

                                                        Point 4 – report from the Board

Highlights of Board’s activities (2)
Projects run by other stakeholders:
EAHP was represented and active in the following
•Council of Europe - EDQM project – statement on
HP production
•PHIS project on pricing and reimbursement of
•EUNetPaS – statement on patient safety (EU project)
•PHARMINE - statement on HP specialisation (EU       See point 6 of the GA
project)                                             agenda
•Other health related associations’events (PGEU,
•eHealth Users Stakeholders Group (with PGEU)
•Tracking system for medicines (Council of Europe –
EDQM) project
•GS1 initiative on tracking systems
•IHE projects and meetings
•Dutch textbook translation

                                                          Point 4 – report from the Board

Highlights of Board’s activities (3)
 Develop with dedicated committees EAHP best
 attended congress ever (3429 participants, 67          See point 7 of the GA
 exhibitors and most profitable congress to date        agenda

 Academy meetings:
 Organise the Seminar (in Belgrade) and begin           See point 7 of the GA
 preparations for the Summit to take place in 2012      agenda

 Internal matters:
 Met with staff and restructured management of office; See point 10 of the GA
 continued legal path to transition Belgian/Dutch EAHP agenda
 into international EAHP

                                                              Point 4 – report from the Board

   Status of EAHP 2010 Survey

         Tajda Miharija Gala
Director of Professional Development

                                       Point 5

EAHP Survey

•       In 2003 the EAHP General Assembly in
    Portorož, Slovenia, decided to run the survey
    every 5 years

               1.   1995 – 18 countries
               2.   2000 – 16 countries
               3.   2005 – 22 countries
               4.   2010 – 30 countries

                                          Point 15– EAHP Survey

EAHP 2005 Survey
• 25 EAHP Member States out of 26
• Electronic questionnaire
• 3517 access codes distributed to hospital pharmacy
• Questionnaire on EAHP website
• June 2005 till October 2005 ;Extended till March 2006
• 22 countries participated (815 hospital pharmacies
• 26 % response rate
                                             Point 15– EAHP Survey

EAHP 2010 Survey

  • GA 2009 in Dubrovnik:
  - to set a working group
  - delegates agreed to be national coordinators
    or help to find the national coordinator

                                       Point 15– EAHP Survey

Working group:
•   Richard Cattell, UK
•   Maria-Jose Tames, Spain
•   Juraj Sykora, Slovakia
•   Ilaria Uomo, Italy
•   Steffen Amann, Germany
•   Joan Peppard, Ireland
•   Andre Rieutord, France
•   Tajda Gala, Slovenia
•   Catherine Hartmann, EAHP

                               Point 15– EAHP Survey

EAHP Survey 2010: Working group
• 1. Questionnaire:
• Prepare / amend the questionnaire – from January on:
-   we took in account, as much as possible, the comments and
    questions of the respondents from the survey 2005 and
    prepare more understandable questions

-   survey questions are mostly the same as those of 5 years ago
    to enable comparison

-   we added some new relevant questions

• - 87 questions in 13 sections: the questions are focused on
  the performance of hospital pharmacies and not on individual
  hospital pharmacists
                                                    Point 15– EAHP Survey

EAHP Survey-Working group:
• 2. Communication:
• Search for the national coordinators who
  would be willing to actively promote the project
  among their colleagues
• Foster the communication on national levels,
  work directly with hospital pharmacy

                                         Point 15– EAHP Survey

    Role of national coordinators
• The national coordinator is either a delegate to
  the EAHP general assembly or a president
  /assigned member of a national association and
  supervised the distribution and data collection
  process (Regional coordinators)
• Facilitate the filling in of the questionnaire
• Promote the survey and strengthen the
  awareness of the importance of presentation of
  the hospital pharmacy profession using the
  results of the EAHP Survey

                                               Point 15– EAHP Survey

EAHP Survey 2010
•AUSTRIA: Silvia HETZ               •IRELAND: Joan PEPPARD
•BELGIUM: Raphael COLLARD           •ITALY: Ilaria UOMO
•            Sofie VERBEKE          •LATVIA: Valdis PIRSKO
•     Tijana MARINKOVIĆ             •LUXEMBURG: Patrick
•BULGARIA: Ilko GETOV               •               ENGELHARDT
•             Nina PURVANOVA        •THE NETHERLANDS: Rob MOSS
•CZECH REPUBLIC: Petr HORAK         •                    Hans OVERDIEK
•         Marijeta DUKARIĆ KURTIĆ   •POLAND: Dariusz SMOLINSKI
•             Gitte NIELSEN         •SERBIA: Dragana RAJINAC
•ESTONIA: Tiia VALS                 •SLOVAKIA: Juraj SYKORA
•FRANCE: Andre RIEUTORD             •SPAIN: María José TAMES
•FYROM: Maja KOVAČEVA               •SWEDEN: Per NYDERT
•GERMANY: Steffen AMANN             •SWITZERLAND: Susanna KUSSMANN
•GREECE: Despina MAKRIDAKI          •TURKEY: Aydin Alper SAHIN
•HUNGARY: Gyöngyver SOOS            •UNITED KINGDOM: Richard CATTELL

                                                         Point 15– EAHP Survey

    EAHP 2010 Survey
• 3. Searching for the company for launching
•    the questionnaire and analysing data – in May

• Three offers: from Germany, UK and Slovenia –
• ORC from UK was selected

• 2 EAHP Board members in charge of the
• project and monitor the response rate regularly
• and work with national coordinators – Juraj
• Sykora and Tajda Gala

                                           Point 15– EAHP Survey

 Distribution of codes

National coordinators were asked in May to
send information on:
• the number of hospitals
• the number of hospital pharmacies
• the way of distribution of the codes to the
  hospital pharmacy managers
• 4898 codes distributed in 31 countries in
  September 2010

                                        Point 15– EAHP Survey

Codes and passwords
• Each hospital pharmacy was provided a unique
  access code

• The number of distributed codes is important for
  calculation of the response rate in a country:

 •   Number of hospital pharmacies = number
         of distributed codes = 100%

                                           Point 15– EAHP Survey

Distribution of codes

• Acces codes were distributed by a
  professional company ORC:
 Directly to hospital pharmacy managers
 To national coordinators
 Fax as a backup if there was no internet

                                      Point 15– EAHP Survey

EAHP Survey 2010 Response Rate

•AUSTRIA:            80%   •ITALY:               39%
•BELGIUM:            18%   •LATVIA:              73%
•BIH:                40%   •LITHUANIA:             9%
•BULGARIA:           30%   •LUXEMBURG:            83%
•CROATIA:            74%   •THE NETHERLANDS:      14%
•CZECH REPUBLIC:     49%   •NORWAY:               45%
•DENMARK:            55%   •POLAND:                 5%
•ESTONIA:           90%    •PORTUGAL:             36%
•FINLAND:           24%    •SERBIA:               45%
•FRANCE:              2%   •SLOVAKIA:             94%
•FYROM:            100%    •SLOVENIA: 9             2%
•GERMANY:           24%    •SPAIN:                 16%
•GREECE:            23%    •SWEDEN:               45%
•HUNGARY:           44%    •SWITZERLAND:          48%
•IRELAND:          44%     •UNITED KINGDOM:         8%

                                               Point 15– EAHP Survey

EAHP Survey 2010 Response Rate
• Best response rate: FYROM 100%
• Highest number of codes: France 1391
• Highest number of answers: Italy 117
                            Germany 102
• Total number of responses: 981
• Turkey did not participate

                                   Point 15– EAHP Survey

Presentation of results
• The data will be presented individually for each
  country to allow comparison between and within
  the countries involved

• Every country will receive a customised CD-
  ROM that will allow for a detailed comparison on
  national level and with other countries across

                                          Point 15– EAHP Survey

Presentation of results
• National analyses/reports were distributed to
• national coordinators by e-mail in May
• Responses? Comments? Errors? Discrepancies?
 Greece – error, later discovered errors in country
•   reports of FYROM, Latvia, UK

 Responses from Germany, Switzerland, Sweden, Bulgaria, UK,
• Poland, Estonia, Norway, Hungary, Italy, BiH, Belgium
• Validation of country reports

                                                   Point 15– EAHP Survey

 Presentation of results
• The results will be presented at the EAHP congress
  in Milan in March 2012
• Booklet EAHP Survey 2010
• National analyses/country reports were distributed
  to national coordinators by e-mail in May
• EAHP website
• European Journal of Hospital Pharmacy EJHP?
• Archives: Secretariat EAHP

                                         Point 15– EAHP Survey

       • Thank you

• for your participation in

• the EAHP 2010 Survey

                        Point 15– EAHP Survey

Coffee break

Reports: projects and working group

• EUNetPaS
  - statement on patient safety (vote)

                                         Point 6.1

Statement on Patient Safety

   -submitted for a vote-

                              Point 6.1

Statement on Patient Safety (1)

Hospital Pharmacists are key stakeholders in medication management in hospitals
   and should be fully engaged by hospital administrators in ensuring the
   judicious, safe, efficacious, appropriate, and cost effective use of medicines. A
   key part of this role is ensuring that for patients receiving care in either a
   hospital setting or in specialised ambulatories, the 7 “rights” are respected i.e.
   right patient, right dose, right route, right time, right drug with the right
   information and the right documentation.

Some of the ways hospital pharmacists can improve patient safety and ensure that
   the seven rights are applied in practice include:

                                                                                  Point 6.1

Statement on Patient Safety (2)

Providing the right advice to patients, physicians and nurses on the safe use of
   medicine and contributing to improved patient outcomes through collaborative
   therapeutic monitoring and decision-making.
Acquiring the additional expertise needed to meet the specific needs of particularly
   vulnerable patient groups such as haemato-oncology, intensive care, infectious
   diseases, and paediatrics.
Reducing medication errors by implementing evidence-based systems or
   technologies, such as automated prescription-filling, unit dose distribution, and
   bar coding systems.
Improving standard operating procedures and patient safety protocols by reporting
   medication errors or adverse reactions to non-punitive national and European
   clinical incident systems.
Procuring the right drugs and related medical devices on the basis of strong safety
   and quality assurance principles and putting in place strategies to cope with
   drug shortages.

                                                                                 Point 6.1

Statement on Patient Safety (3)

EAHP believes that all patients must have equal access to safe high quality
  pharmaceutical care and that in a complex hospital setting this is underpinned
  by the specialized knowledge, skills and experience of the hospital pharmacist.
  There are a number of policies and legislative initiatives on the European
  agenda which represent opportunities for hospital pharmacists to use their
  expertise to advocate for patient safety. This includes the review of EU rules on
  professional mobility, public procurement and clinical trials as well as the
  implementation of EU rules at national level in areas such as
  pharmacovigilance and tackling counterfeit drugs.

EAHP is fully committed to engaging with the EU agenda and using the collective
  experience of hospital pharmacists to advocate for a regulatory framework that
  gives all patients access to safe high quality pharmaceutical care.

                                                                                Point 6.1

Statement on Patient Safety


                              Point 6.1

Reports: projects and working group

           Elfriede Dolinar
            Vice President

                                      Point 12.5

•Pharmaceutical Health Information System
• September 2008 to April 2011
• 5 network meetings
• EAHP was not part from beginning, started at
   2nd network meeting (Roberto Frontini and
   Elfriede Dolinar)
• Aim: increasing knowledge and exchange
   of information on pharmaceutical policies, in
   particular on pricing and reimbursement, in
   the EU Member States, covering both the out-
   patient and the in-patient sector
•-                                               Point 12.5

Participating stakeholders

•Health insurances            •DG Sanko
•Ministries of Health         •DG Enterprise
•National Health Institutes   •WHO Headquarters
•Medicines Agencies           •WHO Europe
•Universities                 •Eurostat
•                             •OECD

                                                  Point 12.5

 Participating countries
              EU                        Outside EU
•Austria, Belgium, Bulgaria,   •Albania, Canada, Croatia,
Cyprus, Czech Rep.,            Iceland, Norway,
Denmark, Estonia, Finland,     Switzerland, Turkey
France, Germany, Greece,
Hungary, Ireland, Italy,
Latvia, Lithuania,
Luxembourg, Malta,
Netherlands, Poland,
Portugal, Romania,
Slovakia, Slovenia, Spain,

                                                     Point 12.5

• Activities since GA 2010
• 4th network meeting
• Rome 27 - 28 September 2010
   • Presentation of SIFO
• 5th network meeting and official end
• Sofia, 28 – 29 April 2011
   • Presentation of Bulgarian Association of               Hospital Pharmacists
   (BAHP) on               activities of the association and Hospital pharmacy in

• Core achievements
• PHIS Glossary
• PHIS Database
• PHIS indicators were developed; the database is
  now in the process of being filled with data from the
  PHIS Pharma Profiles
• Hospital Pharma
• General survey on the pharmaceutical pricing and
  reimbursement policies in the in-patient sector
    • outcomes are country reports
• Case studies for selected hospitals in selected

• Core achievements
• WP Library
• National PHIS Hospital Pharma Reports – country-specific
  reports on the pharmaceutical hospital sector
• Posters – country specific flow-charts on the integrated
  pharmaceutical in- and out-patient sector
• PHIS Pharma Profiles – country specific reports on the
  pharmaceutical in- and out-patient sector
    • WHO decided to copy the idea of producing country reports
    • created another profile broader than just pricing and reimbursement including also
      regulatory issues
    • Pilot in 12 selected countries was started in 2010
    • Global roll-out now

• Sustainability
• Commitment of the the PHIS management team
  at GOEG to continue to work on
   •   reviewing the PHIS Pharma Profiles
   •   validating the data
   •   feeding of the database
   •   further dissemination work
   •   updating of the indicators
   •   revising and extending glossary
• Problem limited scope since there is currently no
  extra funding for the PHIS activities

• Conclusions
• Need for follow-up with appropriate funding
• Interface management should be addressed as
  priority issue
• Integrated approach should be applied
• Mission to disseminate and work on trust-
  building with stakeholders not participating in the
  PHIS network
• Offering different degrees of involvement for
  different stakeholders
• Need to raise interest and funding to guarantee

• PPRI conference 29/30 September 2011 in
• “Balancing pharmaceutical policies between
  equity and cost-containment – a critical
  discussion and lessons learned”
• Organised by the WHO Collaborating Centre of
  Pharmaceutical Pricing and Reimbursement


Reports: projects and working group
• EDQM Magistral preparation:
  - formation of working group
  - statement on HP production (vote)

                                        Point 6.3 & 6.6

• Report from the Director of Education, Science
  and Research, Vagn Handlos:

• Representing the EAHP in the:

  Committee of Experts on Quality and Safety Standards for
     Pharmaceutical Practice and Pharmaceutical Care.

  EDQM European Directorate of the Quality of Medicines and
                   Healthcare. (Ph. Eur.)

                      Council of Europe
                     Strasbourg, France.

                                            The Council of Europe 2011 resolution
• Working party on the

     Quality and safety assurance requirements
               for medicinal products
    prepared in pharmacies for the special needs
                     of patients
•   Resolution #1, 2011 adopted by:
•   Council of Europe Committee of Ministers Jan 19. 2011

•   Working group members from: NL (Chairman), CH,A,N,DK(EAHP).
•   Steering Com.: PL, H, A, IRL, CH, SE, D, NL, DK, P, GB, B, IT,CZ, N.

                                                     The Council of Europe 2011 resolution
•   Former involvement by EAHP (GA):

•   2006.
•   General Assembly Tallinn.
•   Speaker Tobias Gosdschan, PIC-S.
•   Title: GMP-PIC

•   2009
•   General Assembly, Dubrovnik.
•   Henk Scheepers
•   Title: “Harmonization of quality and safety
•   standards for pharmacy preparations in Europe”

•   (Congress and BEAM 2011)

                                                     The Council of Europe 2011 resolution
• Short presentation of the resolution:

                                  The Council of Europe 2011 resolution
   • Statement by the EAHP Board (1)
   • Hospital Pharmacy preparation /production
The need for pharmacy preparations for the special
needs of patients is well established and will continue
to exist in the foreseeable future. This means that
hospital pharmacies (HPs) should have
production/preparation capabilities to fulfil their role in
patient care.
In some cases this could be in form of in house
facilities and in other cases based on contract work or
facilities collectively run by several individual HPs.

                                        Statement on preparatio/production
     • Statement by the EAHP Board (2)

 National guidelines and regulations should be followed. If no regulations are
in force or standards are being developed the two following guidelines should
be used:
In case of large scale production of drugs e.g. injectables, large volume parenterals,
tablets etc., the principles of “Good manufacturing practice (GMP) Guidelines”,
(EurdraLex vol 4) should be complied with or at least recognised as the overall aim in
all aspects of the development and production process.
In case of small scale preparations, the principles of the “Guide to good practices
for the preparation of medicinal products in healthcare establishments”
((PIC/S) Guide PE 010) should be complied with or at least recognised as the
overall aim in all aspects of the development and production process.

                                                           Statement on preparatio/production
  • Statement by the EAHP Board (3)

 Reconstitution of e.g. cytotoxics and antibiotics carried
out according to the Summary of Product Characteristics
(SPC) on the ward or in the hospital pharmacy is neither
production nor preparations as described above.
Reconstitution should be the responsibility of the Hospital
Pharmacist and carried out according to the SPC and
procedures developed in collaboration between the legal
bodies and the hospital pharmacy profession in the
                                        Statement on preparatio/production
•   Formation of a working party.
•   Aims:
•   Members:
•   Frame:
•   (to be filled in after the BM meeting in Dublin)

                                       Statement on preparatio/production
Reports: projects and working groups

   •Dutch textbook translation
   • Development of an European textbook
      •increasing involvement of European experts
      •Incorporation of European standards
   • Aid for professional standards
   • Countervailing Resolution CoE and PIC/S

   •Not just translation: Europeanization

                                                    Point 6.4

•Dutch textbook translation

•Why this book?
•Unique source of information
•Strictly coherent and consistent
•Problem oriented (q.v. brochure)
•Up to date (2009, continuous supervision)
•Many practical examples and formulas
•European regulations incorporated
•Positive feedback from The Pharmaceutical Press
but competition problem with Remington
                                             Point 6.4

•Dutch textbook translation


•Costs editors, authors, project leader: 362 k€
- if external publishing (royalties) at least 95 k€ if 5000 copies
sold at 160 €; but negotiations with publisher have not yet
been carried on
- if EAHP publishes: 5000 × at 160 € = 800 k€ but mind the
printing costs
•Dutch Pharmaceutical Society will donate copyright and stop
Dutch edition.

                                                            Point 6.4

Reports: projects and working group

•Pharmaceutical education in Europe

•EAHP PHARMINE Working Group

•(R. Frontini, J. Sýkora)

                                      Point 6.5

EAHP Pharmine working group
(EAHP working group for hospital pharmacy specialization)

Members of the working group:

Chairman:     1. Roberto Frontini, Germany
Cochairman:   2. Juraj Sykora, Slovakia
Secretary:    3. Inese Sviestina, Latvia
               4. Eric Ackerman, The Netherlands
               5. Nicoletta Ambrogi, Italy
               6. Raisa Laaksonen, Finland,
               7. J.M.Martínez Sesmero, Spain
               8. Anthony Sinclair, UK
               9. Gyongyver Soos, Hungary
              10. Jacqueline Surugue, France

Meetings (June 2010 – June 2011)

1. EAHP Pharmine working group meeting, Brussels,
   4-6 June 2010

2. Pharmine meeting, Catania, Italy, 26 June 2010,

3. EAHP Pharmine working group meeting, Brussels
   15 – 16 October 2010

                                                     Point 6.5

Meetings (June 2010 – June 2011)

4. European Commission: Meeting with professional
   organizations on the evaluation of the professional
   qualification directive 2005/36 EC, Brussels,
   28-29 October 2010

5. EAHP Pharmine working group meeting, Brussels,
   24 January 2011,

6. EAHP Pharmine working group meeting, Amsterdam,
   4-5 February 2011.

                                                         Point 6.5

Main activities in 2010 – 2011

1.   EAHP survey on hospital pharmacy specialization in
     EAHP member countries
     (16 countries with HPS: Austria, Belgium, Croatia, Czech
     Republic, Finland, France, Germany, Hungary, Ireland, Italy,
     Poland, Portugal, Spain, Switzerland, The Netherlands,

2.   EAHP contribution to the final report of the Pharmine
     project advocating specialization in hospital pharmacy

3.   EAHP working group prepared a comprehensive
     document on competencies in hospital pharmacy (part of
     the final report of the Pharmine project)

                                                              Point 6.5

Main activities in 2010 – 2011

4.   EAHP working group prepared a document connecting
     the statements on hospital pharmacy with competencies
     in hospital pharmacy

5.   Members of EAHP Pharmine group were presenters in
     seminars concerning developing and maintaining
     specialization in hospital pharmacy
        Nice 2011: Jaqueline Surugue, Roberto Frontini,
        Vienna 2011: Eric Ackerman, Anthony Sinclair

6.   Members of EAHP Pharmine group prepared Statement
     on Hospital Pharmacy Specialization (document submitted
     to vote on at GA in Dublin 2011)

                                                          Point 6.5
7. EAHP working group will continue to work also in 2011 and 2012

-   Pharmine 2 and 3 – pharmacy education in eastern Europe

-   harmonisation of hospital pharmacy specialization programmes in

-   stimulation of introducing specialization programmes in hospital
    pharmacy in countries without this specialization

-   new methods in hospital pharmacy education, distance learnig, e-

                                                                   Point 6.5

7. EAHP working group will continue to work also in 2011 and 2012

-   centres of excellence in hospital pharmacy, create a system for visits at
    these centres,

-   EAHP conference of Education in hospital pharmacy?

-   e-learning programmes on EAHP web site – for individual and EAHP
    countries, use for accredited further education

-   Pan-european specialization in HP?

                                                                   Point 6.5


Shared By: